Glycospot Invest ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 3.6% 3.6% 3.8% 4.5%  
Credit score (0-100)  0 54 54 51 45  
Credit rating  N/A BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12

Net sales  0 0 0 0 0  
Gross profit  0.0 -50.0 -61.7 -85.9 -75.8  
EBITDA  0.0 -50.0 -61.7 -85.9 -75.8  
EBIT  0.0 -50.0 -61.7 -85.9 -75.8  
Pre-tax profit (PTP)  0.0 -121.0 -167.7 -194.0 -159.0  
Net earnings  0.0 -121.0 -167.7 -194.0 -159.0  
Pre-tax profit without non-rec. items  0.0 -121 -168 -194 -159  

 
See the entire income statement

Balance sheet (kDKK) 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 379 211 17.3 -142  
Interest-bearing liabilities  0.0 0.0 0.0 2,742 2,847  
Balance sheet total (assets)  0.0 5,685 5,648 5,514 4,163  

Net Debt  0.0 -185 -148 2,727 2,813  
 
See the entire balance sheet

Volume 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 -50.0 -61.7 -85.9 -75.8  
Gross profit growth  0.0% 0.0% -23.2% -39.3% 11.8%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 5,685 5,648 5,514 4,163  
Balance sheet change%  0.0% 0.0% -0.6% -2.4% -24.5%  
Added value  0.0 -50.0 -61.7 -85.9 -75.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% -0.9% -1.1% -1.5% -1.5%  
ROI %  0.0% -0.9% -1.1% -2.1% -2.2%  
ROE %  0.0% -31.9% -56.8% -169.8% -7.6%  

Solidity 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
Equity ratio %  0.0% 6.7% 3.7% 0.3% -3.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 369.3% 240.2% -3,175.4% -3,711.8%  
Gearing %  0.0% 0.0% 0.0% 15,886.6% -2,008.1%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 7.9% 3.0%  

Liquidity 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
Quick Ratio  0.0 5.3 2.4 0.0 1.0  
Current Ratio  0.0 5.3 2.4 0.0 1.0  
Cash and cash equivalent  0.0 184.8 148.1 14.3 33.8  

Capital use efficiency 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 149.8 87.5 -5,482.4 -0.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2017
N/A
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0